A double-blind cross-over randomised study was performed to investigate whether Ro15-1788 (Anexate) adequately reversed the conscious sedation with midazolam so that patients were clinically recovered and fit for discharge quicker than when midazolam was used alone. Twentyeight healthy patients between 18 and 34 years sedated with midazolam for bilateral 3rd molar surgery, one side being operated on at each visit. Ro15-1788 or normal saline (placebo) was given at the end of the surgical procedure at the first visit and the alternative at the second visit. Recovery with RoI5-1788 was significantly quicker than with the placebo, both by subjective (86%) and objective (93%) evaluation. Patients' evaluation indicated that only 61% were more alert at home with RoI5-1788. Postoperative adverse effects were similar in both groups.
diazepine, is a benzodiazepine antagonist. Its action is highly specific for agents acting through specific benzodiazepine receptors blocking the central effects of benzodiazepines by competitive interaction at the receptor level. 7 At doses up to 0.1-0.15 mg/kg bodyweight, such side-effects as palpitations, dyspnoea and excitation have been observed. These are said to be due to the anxiolytic effects of the previously given benzodiazepine being completely antagonised. 8 Compared with other agents used to reverse the effect of benzodiazepines, such as physostigmine 9 "o and aminophylline,'1,'2 Ro15-1788 is much more specific in its action. Though it has been successfully used to reverse deep or unconscious sedation with benzodiazepines, it has never been used 8 ,'3-'5 to reverse the effect of conscious sedation with benzodiazepines.
Of the benzodiazepines used for conscious sedation, midazolam is soluble in water, does not produce pain during injection,3,4 and has a low incidence of thrombophlebitis. 4 It also produces profound amnesia. Its action lasts for a shorter time than diazepam due to its short half-life,16 absence of enterohepatic circulation 18 and short-acting metabolites. 16 However, midazolam produces sedation which makes the patient unfit for discharge for about one and a half to two hours. 3 ,6 Therefore, it was decided to assess the reversibility of conscious sedation with midazolam using Ro15-1788 in a double-blind study using the bilaterally and similarly impacted teeth as the surgical model,17,18 with the special emphasis on patients' experience and preference. 19 The protocol and the proforma of consent were approved by the Ethical Committee of the Faculty of Dentistry of the University of Hong Kong.
PATIENTS AND METHODS
Thirty patients of ASA Grade I between the ages of 18-34 years currently taking no medications, needing surgical removal of bilaterally similarly impacted lower third molars, were included in the study following informed consent. The surgery was to be done in two visits by the same surgeon, one side being done at each visit. The patients were instructed to bring a responsible person to accompany them home following each operation.
Preoperatively, the patient was asked to walk in a straight line, pivot around a point, and do Romberg's Test. 6 ,2o Following explanation, he was given a sheet of randomly distributed letters and was asked to delete as many p's as possible within one minute 6 -modified from Thornton and Dixon. 21 This was repeated, and the number of p's deleted and the number of mistakes made were recorded.
In the surgery, the patient was positioned (reclining) in a dental chair. Pulse and blood pressure were recorded and colour, respiration and ECG observed immediately following positioning of the patient, intraoperatively and postoperatively until the patient was fit to leave the clinic.
Midazolam 2 mg (1.0 mg/ml) was administered through a 23-gauge butterfly cannula into a vein in the forearm and two minutes was given for the drug to act. Following this initial dose, midazolam was given at the rate of 1.0 mg/min to a clinical end-point characterised by the drooping of eyelids to bisect the pupils (Verrill's sign),zz The dose of midazolam given and the time at start and termination of injection was noted.
The patient was shown two picture cards and was asked to identify and to remember them.
The surgery was carried out by the same surgeon in a standardised manner after injection of a local anaesthetic (20/0 lignocaine with 1:80,000 adrenaline). The order of the side was randomised. If there were bilateral upper third molars, the corresponding maxillary tooth was removed at the same time.
For reversal of sedation, the patient received either Ro15-1788 or normal saline (placebo). The ampoules, Ro15-1788 1.0 mg in 10 ml and normal saline 10 ml, were packeted by the drug company and had no name of the content other than the number of the patient and the visit, thus making it a double-blind study. At the end of the surgical procedure following grading (see below), the patient was given 2 ml of the solution, allocated to the patient within 15 seconds, into a vein on the dorsum of the hand. A period of two minutes was allowed for the drug to act.
During the injection of the drug, the patient was questioned about pain along the vein of injection if he had not reported it on his own. Local tolerance of the injection was graded as 0= no pain, 1 = slight pain, 2 = moderate pain.
During the two minutes immediately after the injection, the patient was asked whether he could remember the two picture cards shown before and whether he could remember any other injections being given to any part of the body by someone other than the anaesthetist. If he could not answer this, he was given some help by asking him whether he received any injections in the mouth. If he could not recollect any picture cards, he was considered fully amnesic and graded 2 for recall of objects; if he could recollect only one picture card, he was considered partially amnesic and graded 1; and if he could recall both, he was considered not amnesic and graded O. Similarly, if he could not recall any injections being given in the mouth, he was considered fully amnesic for recall of events; if he could recall either injections being given in the mouth or the person who gave the injections, he was considered partially amnesic; if he could recall both, he was considered not amnesic and graded accordingly as before.
At the end of two minutes, grading of recovery was done again. Those who had not recovered were given another 3 ml of the reversal agent at the rate of 1.0 mllmin. No patient received more than 5 ml of the reversal agent. One minute after injection the grading of recovery was repeated.
After 2 ml, if the patient was considered clinically recovered and fit for discharge with an escort, or after 5 ml of the reversal agent, he was shown another two picture cards. He was asked to recall these cards and the cards shown before the operation, 30 minutes later or when he was considered clinically recovered, whichever was the later event. At this time he was shown a big card containing all the pictures shown to patients and asked to identify the four cards shown to him before. Grading was done as before.
The subjective evaluation of the sedation effect was graded preoperatively, at the optimal effect of the sedative, at the end of the operation, and postoperatively after injection of 2 ml, 5 ml of the reversal agent and 15, 30, 60, 90 and 120 minutes after injection of the second dose of the reversal agent until the patient reached the preoperative grade. The following scale was used:
Grade 0 -Patient awake and tense 1 -Patient awake and not tense 2 -Patient drowsy 3 -Patient sleepy but rousable 4 -Patient not rousable Objective evaluation was carried out initially using the p's test. Following surgery it was repeated at the same time as the surgeon's evaluation. Once the patient reached the lower of the preoperative scores of the p's test, patient's ability to walk in a straight line, do Romberg's test and pivot around a point, was assessed. If the patient could not perform any of these tests, then he had to continue to do p's tests until he reached the higher of the preoperative scores, after which he performed the balance tests again.
The patient was assessed as clinically recovered from sedation and fit for discharge with an escort when he was able to walk in a straight line; do Romberg's test and pivot Anaesthesia and Intensive Care, Vol. 15. No. 2, l\1ay, 1987 around a point. As a new drug was being tested, each patient was observed for any side-effects for two hours from the end of the injection of the reversal agent, even after considered clinically recovered. If there were no complications during the two hours, the patient was discharged with an escort.
At the time of discharge, postoperative instructions were given to both the escort and the patient. Diflunisal tablets for analgesia, address and telephone number of hospital to contact if a postoperative complication developed or advice was needed, a simple postoperative questionnaire to determine the postoperative effects of the drugs, and a recording sheet with visual analogue scales to record the postoperative pain on the same day were given to the patient.
The second procedure was done in the same manner as the first procedure, apart from surgery being done on the opposite side and the reversal agent used being the one labelled for the second visit of the patient.
On the seventh day when the patient arrived for suture removal, the postoperative questionnaire and the recording sheet were collected and the sites of injections were examined for evidence of phlebitis, thrombosis or thrombophlebitis.
In addition, one week after the second procedure, the patient was asked after which procedure he was more alert on reaching home and whether he preferred to be alert or sleepy at home after surgery.
The period of recovery was calculated as the interval between the end of injection of the reversal agent and the time of gaining clinical recovery and the period of sedation was calculated as the interval between the end of injection of midazolam and the time of gaining clinical recovery.
The patient's evaluation of recovery was assessed by his observation following which procedure he was more alert at home.
Statistical comparisons were made using the Student's t-test and the Chi Squared test. RESULTS Out of the 30 patients originally included in the study, one patient postponed the second procedure for too long a period to allow for proper patients' evaluation and a second patient did not wish to undergo the second operation. Therefore, these patients were excluded.
Of the remaining 28 patients, 15 were males and 13 females. The average age was 23 (SO 4) years and the average weight was 56.4 (SO 10) kg. The average dose of midazolam needed for sedation was 6.2 (SO 2) mg. The average dose of local anaesthesia used for the lower and upper third molars was 2.2 (SO 0.4) ml and 1.2 (SO 0.3) ml respectively in the Ro15-1788 group and 2.3 (SO 0.3) ml and 1.9 (SO 0.2) ml respectively in the placebo group. Thus, the two groups were comparable with regard to the amount of local anaesthesia given. Mean duration of surgery was 20 (SO 8) minutes in the Ro 15-1788 group and 19 (SO 9) minutes in the placebo group.
Average time from optimum sedation (which was the time at the end of injection of midazolam) to the beginning of injection of the reversal agent was 30 (SO 10) minutes in the Ro 15-1788 group and 31 (SO 9) minutes in the placebo group.
The maximum dose of Ro 15-1788 used in this study was 0.5 mg (5 ml). Nine patients (32070) needed only 0.2 mg (2 ml) to reverse the sedative effect of midazolam.
At the preoperative evaluation, all were assessed to be in Grade 1 of the sedation scale, except one patient in each group who were assessed to be in Grade 0 at the first visit. At optimum sedation, 27 patients in the Ro15-1788 group and 25 patients in the placebo group were assessed to be in Grade 2 of the sedation scale. At the first visit one patient in the placebo group and at the second visit one patient in the Ro15-1788 group and two patients in the placebo group were assessed to be in Grade 3. None in either group was assessed to be in Grade 4 at any stage of evaluation.
Mean period of recovery by subjective evaluation was 1 (SO 12) minute following Ro15-1788 compared with 33 (SO 36) minutes following placebo, (P<O.OOI). Mean period of recovery by objective evaluation was 5 (SO 14) minutes following Ro15-1788 compared with 54 (SO 34) minutes following placebo, (P<O.OOI).
Twenty-four patients (85.7%) were assessed to have recovered quicker with Ro 15-1788 than with placebo by observers' subjective evaluation (Table 1) . Similarly by objective evaluation, 26 patients (92.9%) were assessed to have recovered quicker with Ro15-1788 than with placebo, indicating a significant difference.
In the majority, recovery by objective evaluation with Ro15-1788 occurred within 15 minutes of injecting the reversal agent ( Table  2) . The difference in time between the recovery by objective evaluation with Ro15-1788 and placebo was greater than 15 minutes in 24 out of the 26 patients who recovered quicker with RoI5-1788; in one it was 15 minutes and in another, three minutes. In the majority the difference was 30-60 minutes.
Patient evaluation of recovery showed that 17 (60.7%) were more alert at home following RoI5-1788.
Mean period of sedation by subjective evaluation was 36 (SO 14) minutes following Ro15-1788 compared with 69 (SO 36) minutes following placebo, (P<O.OOI). Mean period of sedation by objective evaluation was 40 (SO 15) minutes following Ro 15-1788 compared with 90 (SO 34) minutes following placebo, (P<O.OOI).
The period of sedation by subjective evaluation was shorter in 26 patients (92.9%) following Ro 15-1788 compared with one following placebo, and by objective evaluation it was shorter in 27 patients (96.4%) following Ro15-1788 compared with one following placebo.
The effect of Ro 15-1788 on mean systolic and mean diastolic blood pressure and heart rate was similar to that of placebo ( Figure 1 ).
Following injection of 2 ml of RoI5-I788, one patient developed hyperventilation and palpitations which subsided in a few minutes, the only side-effect observed following the injection of the reversal agents.
Nearly all patients in both groups exhibited complete amnesia for recall and identification of pictures shown at optimum sedation. The majority of patients in both groups exhibited no amnesia and recalled and identified the pictures shown at the end of injection of the reversal agents. Nearly all patients in both groups exhibited complete amnesia for recall of events during the surgical procedure ( Table 3) .
The postoperative adverse effects on the same day were similar on both occasions (Table  4 ). Pain scores indicated a higher degree of postoperative pain in eleven patients following each reversal agent compared with the other and in six patients there was no difference following the two agents.
At the examination one week postoperatively one patient had thrombosis in a vein in the antecubital fossa where midazolam had been injected.
Twenty-one patients said they wished to be alert after the operation, while six said they wished to be sleepy, and one had no preference.
DISCUSSION
Surgical removal of similarly bilaterally impacted wisdom teeth used as the clinical model in this study is unique in that two separate essentially identical out-patient operations carried out on healthy subjects offer the opportunity to study the intra-individual effect of drugs in a double-blind manner. Since in this model the patient acts as his own control, errors resulting from individual differences are eliminated and the patient is able to determine his preference for one of the two methods. Moreover, fewer patients are required in order to demonstrate the true difference between different treatments compared with a study of parallel groupS.I7.I9
Recovery of patients who undergo sedation in out-patient procedures should be such that they are sufficiently clinically recovered to be discharged following the procedures. I9 This is in contrast to recovery from deep or unconscious sedation in general anaesthesia, which aims at allowing the patient to be transferred to a ward when he is conscious, 12 or recovery from a drug overdose. Evaluation of recovery could be done by subjective evaluation, that is by observing the patient's recovery, and/or by objective evaluation -such as performing psychomotor tests like Bender Gestalt tests,23 p's tests 21 and balance tests,6 like walking in a straight line, pivoting around a point, Romberg's teseo etc. Though subjective evaluation of recovery is sufficient for a patient to be transferred from a recovery room to a ward, it is insufficient to consider a patient clinically recovered for discharge following sedation 19 as in the latter the patient should regain a higher degree of alertness. This finding is confirmed in the present study, where 17 patients were considered to have recovered by subjective evaluation following 0.2 mg of Ro15-1788 whereas only nine patients were considered clinically recovered by objective evaluation.
By objective evaluation, the majority of patients were recovered for discharge more quickly with Ro15-1788 than with placebo. However, in a busy practice for the reversal to be beneficial, the recovery following a reversal agent should be sufficiently accelerated so that patients could be discharged sooner. In this study it was seen that nearly all the patients who recovered more quickly following Ro15-1788 recovered at least 15 minutes sooner than TABLE 4 Postoperative adverse effects Anaesthesia and Intensive Care, Vol. 15. No. 2. May, 1987 following placebo and in the majority the difference in recovery time between the two agents was 30-60 minutes. This is in contrast to aminophylline, which has been shown to reverse deep sedation with diazepam ll ,12 but failed to significantly reverse conscious sedation with midazolam following surgery. 19 In conscious sedation the plane of sedation is lighter than in deep or unconscious sedation. The patient maintains protective reflexes and thus verbal response throughout the period of sedation. The dose of sedative drug needed is also less than that needed for deep or unconscious sedation. Similarly, the dose of reversal agent needed to reverse the effect of the sedative agents used in conscious sedation should be less than that needed for reversal of deep or unconscious sedation. Thus, in this study a maximum of 0.5 mg of the reversal agent was used which was adequate in 92.9070 of the patients and only 0.2 mg was required in 32070.
In the doses used in this study, Ro 15-1788 had no significant effect on blood pressure and heart rate. Side-effects following the injection of the reversal agent were seen only in one patient who, following 0.2 mg of RolS-l788, developed hyperventilation and palpitations, which subsided in a few minutes. These have been reported before. 8 The low incidence of side-effects seems to be very favourable. However, the maximum dose used here was 0.5 mg compared with higher doses needed for reversal of deep sedation, and in this study the majority did not show obvious anxiety before the procedures. With higher doses, and in more anxious patients, the side-effects may occur more frequently. This aspect should be further in vestigated.
Postoperative adverse effects were similar with both reversal agents. It is reported that anti-anxiety effect of midazolam may be reversed by Ro 15-1788. 8 In this study, only two out of 28 patients complained of anxiety following injection of RolS-1788. This may be because of the small dose of RolS-1788 used or because the majority of the population in the study did not show any obvious sign of anxiety at the start of surgery. Postoperative pain scores following both reversal agents did not show any significant difference between the two groups indicating that RolS-I788 did not influence postoperative pain.
Thus, these results indicate the high specificity of action of RolS-1788 in reversing the sedation with benzodiazepines.
Amnesia for events and identification at optimum sedation following midazolam was not reversed by RolS-1788 given at the end of surgery. The majority had no amnesia for pictures shown at the end of the injection of either of the reversal agents. Following doses of midazolam used for conscious sedation, in the majority amnesia for events or identification appears to be present only to those events and pictures shown during a period within 20-25 minutes of optimum sedation. In this study it was not possible to find out whether RolS-I788 reversed the amnesic action of midazolam, as at the time the reversal agent was given the period during which amnesia occurs with midazolam had already elapsed.
Patients' evaluation of alertness at home indicated that only 60.7070 thought that they were more alert at home following RolS-I788. Mean half-life of elimination of RolS-I788 from plasma has been estimated to be 53 minutes 8 whereas for midazolam it varies from 1.7 to 2.4 hours. 25 The above finding is possibly due to the short action of Ro 15-1788 compared with that of midazolam, which suggests that there is a possibility of some degree of resedation following reversal of action of midazolam by Ro 15-1788. Though the patient is discharged earlier following Ro 15-1788, than when it is not used, the patient should be warned that he may feel drowsy at home and should not drive machinery or vehicles.
Four patients were considered to be in Grade 3 of the sedation scale at one visit and in Grade 2 at the alternative visit with the same dose of midazolam. The difference in response at the two visits indicates that not only do different individuals react in different ways to the same dose but each individual also reacts differently on different occasions. Although in this study the same dose of midazolam was given on both occasions for purpose of standardisation, this finding strongly indicates the need for titration of the sedative on each occasion.
Sedation is employed for the comfort of the patient. 26 The search for a reversal agent is also primarily for the comfort of the patient so that the patient can recover more quickly and go home sooner. As seen in this study, although the majority (75070) of the patients preferred to be alert, some patients (21 %) preferred to be sleepy following the operation. Thus, keeping in mind that the prime objective of sedation is patient comfort, the patient must be questioned as to his or her preference to be alert or to be sleepy following the procedure before deciding to administer the reversal agent. 19 
